Breaking News

You are here » Indian-Commodity  :  Top News  :  SAIL aims to increase top-line by 20% in FY17

22-Sep2016

SAIL aims to increase top-line by 20% in FY17

Steel Authority of India (SAIL) is aiming to increase its top-line by 20% to 14.52 million tonnes (MT) this fiscal from 12.1 MT a year-ago. The company is also targeting to increase production by 20% to 17.16 MT in FY17 from 14.3 MT in FY16.

Ramp-up of production from the new units is not only increasing production quantum and leading to better quality of products, but has also helped SAIL in reducing cost of production.

Higher production from the new units and rationalising production from cost intensive routes has resulted in reduction in variable cost of production by 10 per cent in January-March of 2015-16 compared to the first quarter of 2015-16 and the same trend continues.

SAIL is India's largest steel producing company. The company is among the five Maharatnas of the country's Central Public Sector Enterprises. The company has five integrated steel plants, three special plants, and one subsidiary in different parts of the country.


Related News

View all news

Crude oil futures end higher on Friday

Crude oil futures ended higher on Friday on worries about possible impact of US sanctions on Iran's oil exports on crude supply in the market coupled with potential US-Saudi tensions. Prices also supported......

Crude oil futures extend losses on Thursday

Extending previous session losses, crude oil futures ended lower on Thursday due to a sharp jump in US crude inventories last week and on demand growth concerns. The Energy Information Administration's......

Gold futures end higher on Thursday

Gold futures ended higher on Thursday despite rising US dollar on minutes of the Federal Reserve's latest policy meeting indicating that the central bank is staying the course on interest rate hikes.Gold......

Top News

View all news

Bhansali Engineering Polymers reports 33% fall in Q2 net profit

Bhansali Engineering Polymers has reported results for second quarter ended September 30, 2018.The company has reported 32.71% fall in its net profit at Rs 16.89 crore for the quarter under review as compared......

Biocon, Mylan N.V. receive positive CHMP opinion for Ogivri

Biocon and Mylan N.V. have announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Ogivri, a biosimilar......

Lupin Neurosciences receives positive CHMP opinion for NaMuscla

Lupin Neurosciences, a specialty pharma division of Lupin has announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA),......